219 related articles for article (PubMed ID: 16260598)
21. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation.
Zhang H; Zhang R; Luo Y; D'Alessio A; Pober JS; Min W
J Biol Chem; 2004 Oct; 279(43):44955-65. PubMed ID: 15310755
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions.
Jalukar SV; Hostager BS; Bishop GA
J Immunol; 2000 Jan; 164(2):623-30. PubMed ID: 10623803
[TBL] [Abstract][Full Text] [Related]
23. Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.
Portillo JA; Greene JA; Schwartz I; Subauste MC; Subauste CS
Immunology; 2015 Jan; 144(1):21-33. PubMed ID: 25051892
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site.
Grech AP; Gardam S; Chan T; Quinn R; Gonzales R; Basten A; Brink R
J Biol Chem; 2005 Sep; 280(36):31572-81. PubMed ID: 16020544
[TBL] [Abstract][Full Text] [Related]
25. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
[TBL] [Abstract][Full Text] [Related]
26. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
27. The TRAF6, but not the TRAF2/3, binding domain of CD40 is required for cytokine production in human lung fibroblasts.
Purkerson JM; Smith RS; Pollock SJ; Phipps RP
Eur J Immunol; 2005 Oct; 35(10):2920-8. PubMed ID: 16143987
[TBL] [Abstract][Full Text] [Related]
28. CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells.
Li H; Nord EP
Am J Physiol Renal Physiol; 2002 Jun; 282(6):F1020-33. PubMed ID: 11997318
[TBL] [Abstract][Full Text] [Related]
29. TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB.
Uemura N; Kajino T; Sanjo H; Sato S; Akira S; Matsumoto K; Ninomiya-Tsuji J
J Biol Chem; 2006 Mar; 281(12):7863-72. PubMed ID: 16446357
[TBL] [Abstract][Full Text] [Related]
30. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
Sutherland CL; Krebs DL; Gold MR
J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013
[TBL] [Abstract][Full Text] [Related]
31. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
[TBL] [Abstract][Full Text] [Related]
32. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation.
Pype S; Declercq W; Ibrahimi A; Michiels C; Van Rietschoten JG; Dewulf N; de Boer M; Vandenabeele P; Huylebroeck D; Remacle JE
J Biol Chem; 2000 Jun; 275(24):18586-93. PubMed ID: 10764746
[TBL] [Abstract][Full Text] [Related]
33. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of CD40 signaling intermediates.
Werneburg BG; Zoog SJ; Dang TT; Kehry MR; Crute JJ
J Biol Chem; 2001 Nov; 276(46):43334-42. PubMed ID: 11562359
[TBL] [Abstract][Full Text] [Related]
35. PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
Jang HD; Yoon K; Shin YJ; Kim J; Lee SY
J Biol Chem; 2004 Jun; 279(23):24873-80. PubMed ID: 15140884
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of TRAF2 inhibits binding to the CD40 cytoplasmic domain.
Chaudhuri A; Orme S; Vo T; Wang W; Cherayil BJ
Biochem Biophys Res Commun; 1999 Mar; 256(3):620-5. PubMed ID: 10080948
[TBL] [Abstract][Full Text] [Related]
37. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase.
Hatzoglou A; Roussel J; Bourgeade MF; Rogier E; Madry C; Inoue J; Devergne O; Tsapis A
J Immunol; 2000 Aug; 165(3):1322-30. PubMed ID: 10903733
[TBL] [Abstract][Full Text] [Related]
38. The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
Shkoda A; Town JA; Griese J; Romio M; Sarioglu H; Knöfel T; Giehler F; Kieser A
PLoS Biol; 2012; 10(8):e1001376. PubMed ID: 22904686
[TBL] [Abstract][Full Text] [Related]
39. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region.
Ishida T; Mizushima Si; Azuma S; Kobayashi N; Tojo T; Suzuki K; Aizawa S; Watanabe T; Mosialos G; Kieff E; Yamamoto T; Inoue J
J Biol Chem; 1996 Nov; 271(46):28745-8. PubMed ID: 8910514
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.
Habelhah H; Takahashi S; Cho SG; Kadoya T; Watanabe T; Ronai Z
EMBO J; 2004 Jan; 23(2):322-32. PubMed ID: 14713952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
